Correction: Accessibility to molecular studies in gliomas: a challenge for precision medicine in low-resource countries - Summary - MDSpire

Correction: Accessibility to molecular studies in gliomas: a challenge for precision medicine in low-resource countries

  • By

  • Pablo S. Paolinelli

  • Tomas Saavedra Azcona

  • Florencia BCasto

  • Ezequiel Jungberg

  • Nicolás Tilano

  • William ABlettler

  • Joan SPazos

  • Silvina Dell’Era

  • Clara Lynch

  • Miguel Villaescusa

  • Pedro Plou

  • Pablo Ajler

  • June 9, 2026

  • 0 min

Share

Objective:

To correct the funding statement related to the article on accessibility to molecular studies in gliomas.

Key Findings:
  • The original funding statement was incorrect.
  • Servier Argentina provided financial support for the article processing charge.
Interpretation:

The correction clarifies the role of the funder in the research process.

Limitations:
Conclusion:

The article has been updated to reflect the correct funding information.

Original Source(s)

Correction: Accessibility to molecular studies in gliomas: a challenge for precision medicine in low-resource countries

  • by Pablo S. Paolinelli, Tomas Saavedra Azcona, Florencia BCasto, Ezequiel Jungberg, Nicolás Tilano, William ABlettler, Joan SPazos, Silvina Dell’Era, Clara Lynch, Miguel Villaescusa, Pedro Plou, Pablo Ajler

  • June 9, 2026

Related Content

Multi-omics analysis of kidney renal cell carcinoma in silico with preliminary in vivo validation

The value of robot-assisted gastrectomy in the treatment of gastric cancer: a systematic review and meta-analysis

Tetrandrine enhances anti-PD-1 immunotherapeutic efficacy for hepatocellular carcinoma by activating STING/TBK1/IRF3 pathway